Market revenue in 2023 | USD 10.9 million |
Market revenue in 2030 | USD 19.0 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Chemical antidote |
Fastest growing segment | Pharmacological antidote |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Chemical Antidote, Physical Antidote, Pharmacological antidote |
Key market players worldwide | Pfizer Inc, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories, Viatris Inc, Novartis AG ADR, Baxter International Inc, Emergent BioSolutions Inc, Zydus Lifesciences, Fresenius Kabi, Endo Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antidote market will help companies and investors design strategic landscapes.
Chemical antidote was the largest segment with a revenue share of 43.12% in 2023. Horizon Databook has segmented the Denmark antidote market based on chemical antidote, physical antidote, pharmacological antidote covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark antidote market , including forecasts for subscribers. This country databook contains high-level insights into Denmark antidote market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account